Skip to content
Home/Companies/Healthcare/Cisbio Bioassays

Cisbio Bioassays

Healthcare·France·Exited 2016·Held 3yr
Entry
2013
Hold
3yr
Exit
2016

Who owns Cisbio Bioassays?

Cisbio Bioassays was owned by Argos Wityu through Argos Fund VI (2015 vintage) from 2013 to 2016, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-10

Argos Wityu
Investor
Argos Wityu
Argos Fund VI · 2015 · Buyout

Key facts

HQFrance
SectorHealthcare
StatusAcquired
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2016

More from Argos Fund VI

Other portfolio companies in the same fund.

Cohedron
Exited 2022
SoftwareNetherlands· 2017
to
La Compagnie des Desserts
La Compagnie des Desserts
Exited 2023
ConsumerFrance· 2017
to
Melica Software
Exited 2021
SoftwareFrance· 2017
to
Juratoys
Exited 2022
ConsumerFrance· 2016
to
Olinn
Olinn
Exited 2021
TMTFrance· 2016
to
BIP (Business Integration Partners)
Exited 2018
Business ServicesItaly· 2014
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Cisbio Bioassays

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Cisbio Bioassays.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue